XML 30 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
During the quarterly period ended March 31, 2024, the following directors and officers adopted, modified or terminated 10b5-1 plans:
•On February 28, 2024, Charles Dadswell, our General Counsel, entered in a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on December 31, 2024 and provides for the sale of up to 16,695 shares.
•On March 8, 2024, Alex Aravanis, our former Chief Technology Officer, Head of Research and Product Development, terminated a trading arrangement he had previously adopted with respect to the sale of securities of the Company’s common stock in connection with his departure from the Company. The arrangement was adopted on May 9, 2023, had a termination date of May 9, 2024, and provided for the sale of up to 15,486 shares of common stock pursuant to the terms of the plan.
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Charles Dadswell [Member]  
Trading Arrangements, by Individual  
Name Charles Dadswell
Title General Counsel
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 28, 2024
Arrangement Duration 307 days
Aggregate Available 16,695
Alex Aravanis [Member]  
Trading Arrangements, by Individual  
Name Alex Aravanis
Title Chief Technology Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 8, 2024
Arrangement Duration 366 days
Aggregate Available 15,486